Uncoating is an essential step in viral replication cycle. Little is known about the mechanism and requirement of HIV uncoating. Using an in vitro uncoating model, we demonstrate here that the uncoating of HIV-1 was efficiently induced by lysate from activated CD4+ lymphocytes, while quiescent CD4+ lymphocyte lysate was unable to uncoat HIV-1 core. The uncoating activity was associated with an induction of in vitro reverse transcription of the viral genome. Using CD4+ lymphocytes that were arrested in cell cycle, we showed that the uncoating activity required transition of cells from G 0 /G 1a into G 1b stage. These results strongly suggested a requirement of cell cycle-dependent specific factors for HIV-1 uncoating. The putative HIV-1 uncoating factors could be fractionated from cell lysate by gel filtration chromatography. D
Introduction
The events that immediately follow viral penetration into host cell, but precede transcription or translation of the viral genome, are commonly referred to as uncoating. The events require a disassembly of viral capsid in order to release viral genome. For some naked viruses, such as picornaviruses, the capsid does not enter target cell but remains on cell surface while releasing the viral genome through cell membrane into cytoplasm (Greber et al., 1994; Smyth and Martin, 2002) . This entry/uncoating process of picornaviruses is well characterized and led to development of antiviral drugs that block the uncoating process (De Clercq, 2002; Florea et al., 2003; Rossmann, 1988) . For most other viruses, the uncoating process is poorly understood. It is possible that the penetration process itself may trigger the uncoating process. On the other hand, we have several examples of viruses that require specific cellular or viral factors for uncoating. For Sindbis and Semliki Forest viruses, the cellular uncoating factor was identified to be ribosome (Singh and Helenius, 1992) . For influenza virus, the uncoating is triggered by pH change in the virion mediated by an ion channel activity of a viral protein M2 (Sansom et al., 1998) . These suggest that the uncoating process is a tightly regulated process and requires certain cellular or viral factors.
The major reason for our lack of knowledge in viral uncoating is the difficulty in studying this process and the lack of reliable assay. An approach to detect uncoating in vitro is to measure the disassembly of purified core particles after incubation with cell lysate. The difficulty of this assay for HIV is the purification of core particles, which are not stable in the presence of detergent that is needed to strip off the envelope. However, a spin-through technique was described to successfully purify HIV-1 core particles (Accola et al., 2000) . This technique has enabled us to purify intact core particles of HIV-1 that were further used for the development of an HIV-1 in vitro uncoating assay. The principle of the assay is somewhat similar to a previously described assay that has been used to study core stability and an association of Nef with the ribonucleoprotein complex (Forshey and Aiken, 2003; Forshey et al., 2002) .
HIV-1 infection in CD4+ lymphocytes is known to depend on cellular activation status. In quiescent CD4+ T cells, the infection is blocked at an early post-entry step. It was shown that HIV-1 could enter quiescent CD4+ T cells efficiently, but only short incomplete reverse transcripts were made (Borvak et al., 1995; Chou et al., 1997; Tang et al., 1995) . The completion of reverse transcription was shown to require a transition of the cells from G 0 /G 1a into G 1b of cell cycle (Korin and Zack, 1998) . These data led to a hypothesis that some cellular factors that are required for the efficient reverse transcription or strand transfer may be lacked in quiescent CD4+ T cells. We, on the other hand, questioned whether the block was at an earlier step, i.e., the uncoating, resulting in the inefficiency of the subsequent reverse transcription step.
Results
Purification of HIV-1 core particles and the uncoating assay Using a previously described spin-through HIV-1 technique for core particle purification with some modification, we were able to purify core particles without any contamination of enveloped particles as shown by the absence of p17 matrix band in Western blot analysis (Fig. 1a) . With electron microscopy, we were able to show intact core particles with typical size and morphology (Fig. 1b) . The spin-through techniques yielded authentic core with typically higher density than virions that were centrifuged through the same density gradient without detergent (Fig. 1c) .
Since the uncoating process is defined as the disassembly of viral core intracellularly, we attempted to study this process in vitro by detecting the disassembly of core particles in the presence of cellular component. Because purified core of HIV-1 is unstable in the presence of detergent, we obtained detergent-free cell lysate by hypotonic and freeze -thaw lysis. Incubation with lysate from PHA-activated PBMC caused a complete disassembly of the viral core, while incubation with lysis buffer alone did not. This indicated that certain cellular factors could cause the disassembly or uncoating of the viral core (Fig. 2a) . To confirm that the inability to be pellet of the uncoated capsid protein was genuinely due to the disintegration of core particles and not the binding of intact core particles to Fig. 1 . A Western blot analysis of a core particle pellet spun through a discontinuous sucrose gradient with 0.1% Igepal CA-630 (lane 1) comparing with a virion pellet purified by ultracentrifugation (lane 2). We detected the bands with HIV-1 seropositive human serum and HRP-conjugated antihuman immunoglobulin. The arrowheads indicate the positions of the p24 capsid and p17 matrix proteins (a). The purified core shows a typical cone-shaped structure when examined by an electron microscope after negative staining (b). The density of core particles was examined by continuous sucrose density gradient centrifugation. Viral supernatant was centrifuged as described for core particle preparation through 10% sucrose with (solid line) and without 0.1% Igepal CA-630 (dotted line) that was placed on top of a continuous sucrose density gradient. The levels of p24 antigen in the fractions at a dilution of 1:1000 were measured by an ELISA and shown in optical density (OD) (c).
cellular membrane in lysate, we studied the physical status of the uncoated capsid protein. We fractionated the uncoating reaction after fixation in 2% paraformaldehyde. The p24 capsid protein was found in a single peak in the fractions close to that of chymotrypsinogen A, which was used as a molecular size marker and has a molecular weight of 25 kDa (Fig. 2b) . A similar pattern was found when detergent-treated core was fractionated. This suggested that majority of the uncoated capsid protein was released from the viral core as monomer and that the measured uncoating was in fact the result of disintegration of core particles. We further questioned whether the in vitro uncoating was associated with any cleavage of the capsid protein p24. In a Western blot analysis, p24 band remained unchanged after incubation with PHA-activated PBMC lysate (Fig. 2c) . This ruled out the possibility that the observed disassembly was due to non-specific degradation of the capsid protein by a cellular protease. In order to show the release of the inner content of the core after disassembly, we measured the RT activity in the supernatant of the uncoating assay after ultracentrifugation. Expected amounts of RT activity were equally found in the reaction with disruption buffer and cell lysate, while only background level of activity was detected in the negative control with hypotonic lysis buffer (Fig. 2d) .
The lack of uncoating activity in quiescent CD4+ lymphocytes
Because of the block in HIV replication cycle in quiescent CD4+ lymphocytes at an early post-entry step, we questioned whether this might be due to the lack of uncoating in those cells. To test this hypothesis, we purified quiescent (CD4+/HLA-DRÀ/CD69À/CD25À) and activated (CD4+/HLA-DR+) cells from PBMCs of normal healthy donors by a fluorescence-activated cell sorter. We purified quiescent cells from freshly isolated PBMC, but for activated cells we used PHA-activated PBMC in order to obtain enough number of fully activated cells. In whole PBMC, PHA-activation enhanced the uncoating activity (data not shown). The purity of the cell preparation was consistently more than 98% and 90% for the quiescent and activated cell fractions, respectively. There was no contamination of monocyte in the quiescent cell preparation as demonstrated by the lack of CD14+ cell (Fig. 3a) . And these purified quiescent cells were refractory to productive infection by HIV-1. In spite of the lower purity of activated cell population, monocyte did not contribute to the observed uncoating activity. They were excluded from the sorted population by their higher SSC, and sorted purified monocytes had much lower uncoating activity than activated CD4+ lymphocytes (data not shown). Majority of contaminating cells in the activated cell population were quiescent cells. We also demonstrated that the sorted quiescent cells were in G 0 /G 1a by cell cycle analysis (Fig.  3b) . Cell lysate from HLA-DR-negative cells did not show any uncoating activity, while the lysate from HLA-DRpositive cells induced efficient disassembly of the viral core. Even with 10 times higher cell concentration, the HLA-DRnegative cells were unable to induce significant viral core disassembly (Fig. 3c) . The number of activated cells in this experiment was 10 times lower than that of whole PBMC in Fig. 2 with similar level of uncoating activity. This suggested the enrichment of uncoating activity by purifying activated cells from other uncoating-inactive cells. Because quiescent cells are smaller and may have lower protein content, we also tested the uncoating activity in activated and quiescent cells after normalization of protein concentration by a Bradford colorimetric assay and found a similar level of difference as seen in experiments with cell number normalization (data not shown). In accordance with the lack of uncoating activity in quiescent cell lysate, full-length reverse transcription product could not be induced by the quiescent cell lysate, while incubation under the same conditions with activated cell lysate resulted in production of a full-length reverse transcription product (Fig. 3d) .
Uncoating activity and the cell cycle
It has been previously shown that the susceptibility to HIV-1 infection in CD4+ lymphocytes depended on the transition of cells from G 1a to G 1b in the cell cycle. We therefore asked whether this cell cycle-dependent susceptibility was due to a gaining of the ability to uncoat HIV core. To obtain CD4+ lymphocytes arrested in G 0 -G 1a and G 1b , we treated freshly prepared PBMCs with n-butyrate (5 AM) and aphidicolin (10 mM), respectively, in the presence of PHA for 3 days. Cell viabilities were determined by trypan blue dye exclusion and found to be comparable in control and treated cells. CD4+ cells were then purified by fluorescence-activated cell sorting from untreated, aphidicolin-, and n-butyrate-treated cells. While untreated cells and the G 1b arrested (aphidicolin-treated) cells induced comparable core disassembly, the G 0 -G 1a arrested (n-butyrate-treated) cells lacked the uncoating activity (Fig. 4) . This result was in agreement with previously published data and suggested that the cellcycle-dependent block in HIV-1 replication cycle was at least in part due to the lack of uncoating activity in quiescent G 0 -G 1a cells.
Uncoating factor
Our data suggested the existence of a cellular uncoating factor. Besides activated CD4+ T cells, the uncoating activity was also found in various T-cell lines, such as SupT1 and H9. The fraction containing uncoating activity could be precipitated with 80% but not 40% ammonium sulfate (data not shown). We attempted to partially purify Fig. 4 . The treatment of PHA-activated PBMC with the cell cycle inhibitor n-butyrate, which stops the cell cycle at G 0 -G 1a , inhibited the uncoating activity of sorted CD4+ lymphocytes, while the treatment with Aphidicolin, which accumulated cells at G 1b , did not affect the uncoating (a). Cell cycle analysis confirmed the cell cycle arrest by the inhibitors. The y-axis shows DNA content stained with 7AAD and the x-axis shows RNA content stained with PY. The dot plots separate cells in G 0 -G 1a into the left lower quadrant, G 1b into the right lower quadrant, and S/G2/M into the right upper quadrant (b). the putative uncoating factor by FPLC. We found the uncoating activity mainly in a fraction representing molecular size of approximately 60 kDa. A minor peak of uncoating activity was also found in a fraction representing molecular size of approximately 160 kDa (Fig. 5) .
Discussion
Virus uncoating is one of the least studied processes in the viral replication cycle. What we learned from a number of viruses, of which the uncoating processes have been elucidated, was that the viral uncoating is a multi-step process triggered by virus -cell interaction. Because we were able to purify intact core particles, which were quite stable even in the presence of some detergent, the capsid disassembly could not be a spontaneous process triggered only by the lost of contact between capsid and envelope or matrix. The process therefore needed a specific trigger, most likely provided by the intracellular environment. This putative uncoating factor could theoretically contribute to some of the unknown aspect of cell tropism. Here we show that uncoating block could be another factor responsible for the insusceptibility of quiescent T-cells. Theoretically, the lack of uncoating activity in quiescent cells could be due to either a lack of uncoating factor or a presence of uncoating inhibitor. The uncoating activity in unsorted PBMC despite the presence of quiescent cells outnumbering activated cells argues against the presence of uncoating inhibitor.
We do not know whether uncoating block is the sole reason for the insusceptibility of quiescent cells. It is quite possible that factors required in several steps of the establishment of provirus are absent in quiescent cells. Although quiescent CD4+ lymphocytes are refractory to HIV infection in vitro, cells from infected persons are known to harbor latent proviral DNA (Chun et al., 1997; Seshamma et al., 1992) . These cells are believed to acquire infection in a stage beyond G 0 /G 1a and then return to quiescent stage after the establishment of provirus. Recent studies suggested that a cell does not have to be fully activated to support HIV infection. T cells without activation markers could be made susceptible to HIV infection through the actions of cytokines and the viral protein Nef (Swingler et al., 2003; Unutmaz et al., 1999) . It is likely that these subtle stimulatory signals are sufficient to activate uncoating activity in quiescent cells together with specific requirements for other steps of the viral replication. Because infection in permissive resting cells is perhaps more likely to result in a latent infection, it is important to determine the difference between refractory and permissive quiescent cells. This would help us to understand the establishment and maintenance of viral reservoir.
In accordance to previous reports using similar approach, our core preparation lacked matrix protein (Fig. 1a) . The matrix protein is a component of preintegration complex. Therefore, it should accompany the core into cytoplasm. However, the role of the matrix protein is to transport the preintegration complex into nucleus, and there is no evidence that the matrix protein is involved in the uncoating process. Current HIV maturation model also suggests that there is no direct interaction between core and matrix in a mature virion (Bukrinskaya, 2004) . Together, these suggest that the uncoating process can be studied in vitro using purified core without the matrix. On the other hand, it is also possible that opening of the matrix coat would also require a specific trigger, which is not addressed in this study.
Current model of mature HIV-1 capsid composes of hexameric rings of p24 protein held together by a dimeric interaction of p24 between adjacent rings (Briggs et al., 2003; Welker et al., 2000) . Previous data showed that the p24 capsid protein could form dimer but not hexamer in solution. This suggested that the C-domain to C-domain dimeric interaction was stable while the N-domain to N-domain hexameric interaction was not and could only exist with intact C-domain to C-domain and N-domain to C-domain intermolecular interactions (Lanman et al., 2003) . If the dimeric interaction is disrupted, deducing from the model, it is likely that the hexameric structure would be destabilized resulting in the release of monomeric p24 protein. Our data showing monomeric p24 capsid protein from the uncoated core suggested that the C-domain to C-domain interaction is likely to be the target of the uncoating process.
Our data have demonstrated the existence of at least two distinct cellular uncoating factors. These putative uncoating factors are macromolecules and may have molecular mass of approximately 60 and 160 kDa. Further studies to elucidate the nature of the uncoating factors and the mechanism of uncoating will provide insights to this yet obscure step in the HIV life cycle. For many viruses, the uncoating step has been shown to be a successful target for development of anti-viral drugs, for example, Pleconaril for enteroviruses (De Clercq, 2002; Florea et al., 2003) . More understanding in the uncoating of HIV-1 will hopefully provide us a novel target for anti-viral drug development.
Materials and methods

Purification of HIV-1 core particles
HIV-1 IIIB was harvested from supernatant of infected SupT1 cells on days 3-5 post-infection when maximum cytopathic effect was observed. The infected cells were maintained in RPMI 1640 medium with 10% fetal calf serum (FCS). The culture medium was changed 24-48 h before the harvest. Viral core particles were then purified by a spin-through technique as previously described (Accola et al., 2000) with some modification. Three milliliters of cell-free supernatant was overlayered on a discontinuous sucrose density gradient. The gradient was composed of 1 ml of 50% sucrose at the bottom and 1 ml of 10% sucrose containing 0.1% Igepal CA-630 on the top. The overlayered gradient was then centrifuged at 100,000 Â g in a SW50.1 rotor (Beckman) for 2 h at 4 -C. The pellet containing viral core particles was then resuspended in 5 Al of PBS, pooled, and stored in aliquots at À80 -C. The core particles were quantitated by measuring the capsid p24 antigen with an ELISA kit (Vironostika, Organon Teknika).
For Western blot analysis, virion and core preparations were mixed with loading buffer, heated in boiling water bath for 5 min, and loaded onto a 12% polyacrylamide gel. After a semidry electroblotting, the nitrocellulose membrane was incubated in Tris-buffered saline (TBS) containing 5% skim milk and HIV-1-positive serum at dilution 1:100 overnight at 4 -C, washed 4 times in TBS, incubated in TBS/5% skim milk containing horseradish peroxidase-conjugated goat antihuman immunoglobulin (Sigma) for 1 h at room temperature, and washed 4 times in TBS. The signal was then developed by incubating the membrane in TBS with 0.6 mg/ml diaminobenzidine (DAB) and 0.03% hydrogen peroxide.
Cell sorting and cell lysate preparation
Freshly isolated peripheral blood mononuclear cells (PBMC) from healthy donors were stained with peritinin chlorophyll-a-proteins complex (PerCP)-conjugated anti-CD4, phycoerythrin (PE)-conjugated anti-HLA-DR, PEconjugated anti-CD69, and Fluorescein isothiocyanate (FITC)-conjugated anti-CD25 monoclonal antibodies (Becton Dickinson). Quiescent CD4+/HLA-DRÀ/ CD69À/CD25À lymphocytes were sorted by a fluorescence-activated cell sorter (FAC Vantage). The lymphocyte population was gated by its low side scatter (SSC) and the staining profiles. For purification of activated CD4+ cells, PBMCs were cultured in RPMI 1640 + 10% FCS supplemented with 10 Ag/ml of phytohemagglutinin (PHA) for 3 days, stained with anti-CD4 and anti-HLA-DR antibodies, and CD4+/HLA-DR+ lymphocytes were sorted similarly. The sorted cells were analyzed for purity by flow cytometry with additional staining of anti-CD14 to monitor the contamination of monocyte, and by cell cycle analysis as described (Korin and Zack, 1998) . For cell cycle analysis, cells were resuspended in 0.5 ml of staining buffer (0.15 M NaCl, 0.1 M phosphate-citrate buffer, 5 mM EDTA, 0.5% bovine serum albumin, 0.03% saponin) with 50 AL of 400 AM 7-amino-actinomycin D (7AAD). After 30-min incubation at room temperature, the cells were chilled on ice for 5 min, and 50 AL of 100 AM pyronin Y (PY) was added. The cells were further incubated on ice for 10 min and then analyzed by flow cytometry. The DNA and RNA contents were measured using linear scales of FL3 and FL2, respectively.
Cell lysate was prepared by resuspending washed cell pellets in hypotonic lysis buffer (10 mM Tris pH 7.4, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT). The cell suspension was frozen and thawed, incubated on ice for 10 min, and centrifuged at full speed in a refrigerated microcentrifuge for 5 min. The supernatant was then stored at À80 -C until used in uncoating assay.
Uncoating assay
Purified core particles (1 ng in 2 Al of PBS) were incubated with 2 Al of cell lysate at 37 -C for 30 min, then diluted in 5 ml of PBS and centrifuged at 100,000 Â g in a SW50.1 rotor (Beckman) for 2 h at 4 -C. Incubations with hypotonic lysis buffer and p24 disruption buffer (Vironostika, Organon Teknika) were done in parallel as negative and positive controls. The extent of core disintegration was determined by measuring the level of p24 in the supernatant after centrifugation. The complete disruption of core by p24 disruption buffer was considered 100%, and percent disruption by lysates was calculated accordingly.
Reverse transcriptase activity and endogenous reverse transcription assay
Reverse transcriptase (RT) activity in the supernatant of uncoating assay after ultracentrifugation was determined using an assay modified from a previously described method (Heneine et al., 1995) by incubating 1 Al of the supernatant in 10 Al of solution containing 1 Â RT buffer (50 mM Tris -HCl, 50 mM KCl, 50 mM MgCl 2 , 2.5 mM spermidine, 50 mM DTT), 0.6% NP-40, 0.5 mM dNTP, 10 ng of EMCV (encephalomyocarditis virus) RNA template, 4 pmol of EMCV primer, and 8 unit of RNase inhibitor. Avian myeloblastosis virus (AMV)-RT at 10 4 , 10 2 , and 1 unit per reaction was used to set a standard curve for quantitation. The reactions were incubated at 42 -C for 1 h and inactivated at 95 -C for 5 min. The cDNA product was then measured by a real-time PCR in a SYBR Green dye detection format.
Endogenous reverse transcription reactions were done in 5-Al volume containing 1 ng of core particles, 1 Â RT buffer, 2 mM dNTPs, and 2 Al of cell lysate from sorted activated or quiescent lymphocytes (2.5 Â 10 4 cells/Al). The reactions were incubated at 37 -C for 1 h, then heated in boiling water bath for 5 min. The full-length reversetranscribed products were then detected by PCR using the primers RU5S (GGCTAACTAGGGAACCCACTG) and FL-DNA (CAGGTCCCTGTTCGGGCGCC) (Borvak et al., 1995) . The thermal cycle was 28 cycles of 94 -C for 30 s, 42 -C for 30 s, and 72 -C for 30 s.
Fast protein liquid chromatography (FPLC)
Size exclusion chromatography of H9 cell lysate was done using a Superdex 200 gel filtration column on an AKTA FPLC system (Pharmacia Biotech). A 200-Al sample at protein concentration of 5 mg/ml of H9 lysate was injected, then eluted with phosphate-buffered saline at a flow rate of 1 ml/min. Absorbance was measured at 214 nm. Fractions (1 ml) were collected using a Frac-900 fraction collector (Pharmacia Biotech). Collected fractions were precipitates with 90% ammonium sulfate, resuspended in 25 Al of PBS, and 10 Al was tested for uncoating activity as described above. For fractionation of uncoated p24 protein, an uncoating reaction was fixed in 2% paraformaldehyde, injected onto a Superdex 75 column, and then eluted with similar elution conditions.
